Skip to main content
. Author manuscript; available in PMC: 2022 Aug 10.
Published in final edited form as: Acad Emerg Med. 2020 May 19;27(11):1126–1139. doi: 10.1111/acem.14000

Table 3.

Reduction in symptoms over time among the full sample (n = 47) and the exploratory subsample of black patients (n = 21).

Outcomes: Full Sample (n = 47) Baseline Mean (SD) 30-day Follow-up (SD) Change over time Mean (SD) 95% CI 90-Day follow-up Mean (SD) Change over time Mean (SD) 95% CI

PTSS - 25.73 (19.96) - - 19.33 (18.97) 6.40 (11.38) 2.98; 9.82
PTSS Coping Self- Efficacy 70.12 (19.26) 65.34 (27.53) 4.78 (23.05) −1.64; 11.19 71.55 (27.72) −0.85 (25.70) −8.48; 6.78

Outcome: Subsample (n = 21)

PTSS - 30.00 (21.20) - - 23.21 (12.71) 6.79 (11.18) 1.40; 12.17
PTSS Coping Self- Efficacy 64.31 (21.26) 53.99 (31.93) 10.32 (28.15) −2.50; 23.13 61.43 (33.11) 4.62 (32.47) −10.16; 19.41

Note. The change sore for PTSS represents the change from 30 to 90 days given that PTSS stemming from the index injury were not assessed at baseline. The change scores for PTSS Coping Self-Efficacy represent the change from baseline to 30-days, and the change from baseline to 90-days.

(SD) = Standard deviation; PTSS = Posttraumatic Stress Symptoms.

*

P <.05

**

P <.01

***

P <.001.